These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31445964)

  • 21. Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy.
    Traboulsi-Garet B; Jorba-García A; Camps-Font O; Alves FA; Figueiredo R; Valmaseda-Castellón E
    Clin Oral Investig; 2022 Mar; 26(3):2371-2382. PubMed ID: 35124731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
    Al-Omari FA; Kuroshima S; Sawase T
    J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis.
    Momesso GAC; Lemos CAA; Santiago-Júnior JF; Faverani LP; Pellizzer EP
    Oral Maxillofac Surg; 2020 Jun; 24(2):133-144. PubMed ID: 32056052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors.
    Brijs K; Miclotte I; Vermeire S; Darche V; Politis C
    Int J Oral Maxillofac Surg; 2020 Mar; 49(3):317-324. PubMed ID: 31466830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw.
    Fung PL; Nicoletti P; Shen Y; Porter S; Fedele S
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):537-46. PubMed ID: 26299425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.
    Van Poznak C; Reynolds EL; Estilo CL; Hu M; Schneider BP; Hertz DL; Gersch C; Thibert J; Thomas D; Banerjee M; Rae JM; Hayes DF
    Oral Dis; 2022 Jan; 28(1):193-201. PubMed ID: 33274559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRONJ risk of adjuvant bisphosphonates in early stage breast cancer.
    Patel V; Mansi J; Ghosh S; Kwok J; Burke M; Reilly D; Nizarali N; Sproat C; Chia K
    Br Dent J; 2018 Jan; 224(2):74-79. PubMed ID: 29242516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case series of medication-related osteonecrosis of the jaw (MRONJ) patients prescribed a drug holiday.
    Hamid A; Thomas S; Bell C; Gormley M
    Br J Oral Maxillofac Surg; 2023 Apr; 61(3):227-232. PubMed ID: 36935312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
    Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
    Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study.
    Zhou Y; Yu Y; Shi Y; Li M; Yang C; Wang S
    Biomed Res Int; 2020; 2020():5847429. PubMed ID: 33123580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review.
    Sacco R; Umar G; Guerra RC; Akintola O
    Br J Oral Maxillofac Surg; 2021 Jul; 59(6):648-660. PubMed ID: 34023155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
    Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
    J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.
    Jiang A; Zhang Z; Qiu X; Guo Q
    Arch Toxicol; 2024 Mar; 98(3):689-708. PubMed ID: 38155341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of illicit drugs in developing medication-related osteonecrosis (MRONJ): a systematic review.
    Sacco R; Ball R; Barry E; Akintola O
    Br J Oral Maxillofac Surg; 2021 May; 59(4):398-406. PubMed ID: 33789811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
    Khominsky A; Lim M
    Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Influencing Severity of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study.
    Feng Z; An J; Zhang Y
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1683-1688. PubMed ID: 33529608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib.
    Mauceri R; Panzarella V; Morreale I; Campisi G
    Int J Oral Maxillofac Surg; 2019 Dec; 48(12):1530-1532. PubMed ID: 31378564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.